TELL v.2.0, Editor’s Choice of DEMCOG

Our paper on TELL v.2.0 was the Editor’s Choice of Dementia and Geriatric Cognitive Disorders 54(2), 2025. Congratulations to the whole team! To read the full paper, click here.

Can digital speech testing help reduce global health inequity?

While rising global life expectancy is a major achievement, it leads to more people encountering neurodegenerative diseases like Alzheimer’s and Parkinson’s. Digital speech biomarkers offer a promising tool for large-scale, low-cost screening and monitoring of neurodegenerative disorders. Emerging collaborations are actively working to democratize access to speech-based diagnostics. To read the full article, please click here.

New investment for TELL from Uruguay Innovation Hub

Co-investment for TELL from Uruguay Innovation Hub. We are very excited to be part of this new ecosystem, hand in hand with The Ganesha Lab! Learn more about Uruguay Innovation Hub here and The Ganesha lab here.